[Effect of administration of blood products on the course of tetanus antibody concentration in immuno-incompetent patients].

Infusionstherapie und Transfusionsmedizin Pub Date : 1996-02-01

M Pietsch, S Töre, K H Schütt

{"title":"[Effect of administration of blood products on the course of tetanus antibody concentration in immuno-incompetent patients].","authors":"M Pietsch, S Töre, K H Schütt","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: Collecting of data for immunoprophylaxis of tetanus in immunodeficient patients via administration of blood products.Design: Prospective single case studies.Setting: Clinical therapy in a department of hematology with continuous determination of tetanus antibody concentrations in patients' sera and administered blood products with an enzyme immunoassay.Patients: 3 patients with acute myeloid leukemia (FAB classifications M1, M3, M4).Interventions: Regular administration of blood products due to clinical therapy.Results: After administration of about 4,000 IU tetanus antitoxin i.v., serum concentration is increasing by 1 IU/ml. Half life in serum amounts to 7 days. Protection lasts therefore up to 6 weeks.Conclusions: Immunodeficient patients may receive a medium-term effective protection against tetanus after selection of suitable blood products. This method is interesting also for prophylaxis of postoperative tetanus in immunocompetent patients.","PeriodicalId":13632,"journal":{"name":"Infusionstherapie und Transfusionsmedizin","volume":"23 1","pages":"25-8"},"PeriodicalIF":0.0000,"publicationDate":"1996-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusionstherapie und Transfusionsmedizin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Collecting of data for immunoprophylaxis of tetanus in immunodeficient patients via administration of blood products.

Design: Prospective single case studies.

Setting: Clinical therapy in a department of hematology with continuous determination of tetanus antibody concentrations in patients' sera and administered blood products with an enzyme immunoassay.

Patients: 3 patients with acute myeloid leukemia (FAB classifications M1, M3, M4).

Interventions: Regular administration of blood products due to clinical therapy.

Results: After administration of about 4,000 IU tetanus antitoxin i.v., serum concentration is increasing by 1 IU/ml. Half life in serum amounts to 7 days. Protection lasts therefore up to 6 weeks.

Conclusions: Immunodeficient patients may receive a medium-term effective protection against tetanus after selection of suitable blood products. This method is interesting also for prophylaxis of postoperative tetanus in immunocompetent patients.

微信好友朋友圈 QQ好友复制链接

本刊更多论文

血液制品对免疫功能不全患者破伤风抗体浓度变化的影响。

目的:收集免疫缺陷患者血液制品免疫预防破伤风的资料。设计:前瞻性单一案例研究。环境:血液科的临床治疗，连续测定患者血清中的破伤风抗体浓度，并用酶免疫测定法给予血液制品。患者:急性髓系白血病3例(FAB分型M1、M3、M4)。干预措施:因临床治疗需定期给予血液制品。结果:注射破伤风抗毒素约4000 IU后，血清浓度升高1 IU/ml。血清中的半衰期为7天。因此，保护期长达6周。结论:免疫缺陷患者在选择合适的血液制品后，可获得中期有效的破伤风保护。该方法对免疫功能正常患者术后破伤风的预防也很有意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Infusionstherapie und Transfusionsmedizin

自引率

0.00%

发文量